Morio Matsumoto

ScholarGPS® ID: 50546722463332

Affiliation

Gunma University, Maebashi, Japan

Affiliation History

Field

Medicine

Discipline

Hematology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

3,219

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain (journal article) Iriuchishima, Hirono \| Saito, Akio \| Mihara, Masahiro \| Terasaki, Yukie \| Matsumoto, Akira \| Isoda, Atsushi \| Furukawa, Yusuke \| Matsumoto, Morio International Journal of Hematology (2024). 10.1007/s12185-024-03760-w Cited by (2) \| Cite \| Source
Revealing cyclic thrombocytopenia: The role of periodogram analysis and the impact of thrombopoietin receptor agonist therapy (journal article) Isoda, Atsushi \| Kurashina, Hiroaki \| Usami, Reo \| Terasaki, Yukie \| Akashi, Naoki \| Mihara, Masahiro \| Iriuchishima, Hirono \| Saito, Akio \| Matsumoto, Morio \| Sawamura, Morio International Journal of Laboratory Hematology (2024). 10.1111/ijlh.14278 Cite \| Source
NK and T-lymphocyte Kinetics Predict Outcome in Myeloma Patients Treated With Elotuzumab, Lenalidomide Plus Dexamethasone (journal article) Suzuki, Kazuhito \| Matsumoto, Morio \| Hiramatsu, Yasushi \| Takezako, Naoki \| Tamai, Yotaro \| Suzuki, Kenshi Cancer Diagnosis & Prognosis, volume 4, issue 2, pages 97-104 (2024). 10.21873/cdp.10293 Cite \| Source
Severe lactic acidosis during tenofovir disoproxil fumarate and cobicistat combination for HIV patient (journal article) Isoda, Atsushi \| Mihara, Masahiro \| Matsumoto, Morio \| Sawamura, Morio BMJ Case Reports, volume 16, issue 11, pages e255751- (2023). 10.1136/bcr-2023-255751 Cited by (1) \| Cite \| Source
Isolated ACTH deficiency: an uncommon cause of hyperferritinaemia (journal article) Isoda, Atsushi \| Saito, Akio \| Matsumoto, Morio \| Sawamura, Morio BMJ Case Reports, volume 16, issue 10, pages e256049- (2023). 10.1136/bcr-2023-256049 Cite \| Source
P-316 NK cell kinetics predict outcome in the multiple treated with elotuzumab, lenalidomide plus dexamethasone (ERd): a subanalysis in Japanese multicenter observation for once monthly ERd study (journal article) Suzuki, Kazuhito \| Matsumoto, Morio \| Takezako, Naoki \| Hiramatsu, Yasushi \| Tamai, Yotaro \| Yano, Shingo \| Suzuki, Kenshi Clinical Lymphoma Myeloma and Leukemia, volume 23 (2023). 10.1016/S2152-2650(23)01934-1 Cite \| Source
Prevalence and clinical outcomes of vitamin D deficiency among Japanese multiple myeloma patients: a single-center observational study (journal article) Isoda, Atsushi \| Miyazawa, Yuri \| Ishikawa, Tetsuya \| Kanaya, Shuhei \| Nakayama, Keita \| Mihara, Masahiro \| Iriuchishima, Hirono \| Saito, Akio \| Matsumoto, Morio \| Sawamura, Morio Supportive Care in Cancer, volume 31, issue 9 (2023). 10.1007/s00520-023-08021-w Cited by (2) \| Cite \| Source
A phase 3, open-label, randomized study to evaluate the efficacy and safety of single-agent belantamab mafodotin (belamaf) compared to pomalidomide plus low-dose dexamethasone (Pd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): DREAMM (journal article) Weisel, Katja \| Hungria, Vania TM \| Radinoff, Atanas \| Delimpasi, Sosana \| Mikala, Gabor \| Masszi, Tamas \| Li, Jian \| Capra, Marcelo \| Matsumoto, Morio \| Sule, Neal \| ... \| Dimopoulos, Meletios A. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 8007-8007 (2023). 10.1200/JCO.2023.41.16_suppl.8007 Cited by (7) \| Cite \| Source
Once Monthly Elotuzumab and Lenalidomide Plus Dexamethasone for Multiple Myeloma: A Multicenter Observation Study (journal article) Suzuki, Kazuhito \| Matsumoto, Morio \| Hiramatsu, Yasushi \| Takezako, Naoki \| Tamai, Yotaro \| Suzuki, Kenshi Acta Haematologica, volume 146, issue 2, pages 125-136 (2023). 10.1159/000528700 Cite \| Source
S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3) (journal article) Dimopoulos, Meletios A. \| Hungria, Vania \| Radinoff, Atanas \| Delimpasi, Sosana \| Mikala, Gabor \| Masszi, Tamas \| LI, Jian \| Capra, Marcelo Eduardo \| Matsumoto, Morio \| Sule, Neal \| ... \| Weisel, Katja HemaSphere, volume 7, issue S3, pages e072005a- (2023). 10.1097/01.HS9.0000967708.07200.5a Cited by (2) \| Cite \| Source
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment (journal article) Matsue, Kosei \| Sunami, Kazutaka \| Matsumoto, Morio \| Kuroda, Junya \| Sugiura, Isamu \| Iwasaki, Hiromi \| Chung, Weiyuan \| Kuwayama, Shigeki \| Nishio, Mitsufumi \| Lee, Kim \| Iida, Shinsuke International Journal of Hematology, volume 116, issue 1, pages 122-130 (2022). 10.1007/s12185-022-03338-4 Cited by (2) \| Cite \| Source
Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting (journal article) Yoroidaka, Takeshi \| Takamatsu, Hiroyuki \| Itagaki, Mitsuhiro \| Yoshihara, Satoshi \| Sato, Kota \| Takezako, Naoki \| Ozaki, Shuji \| Suzuki, Kazuhito \| Kohno, Kentaro \| Matsumoto, Morio \| ... \| Shimizu, Kazuyuki Blood, volume 138, issue Supplement 1, pages 3946-3946 (2021). 10.1182/blood-2021-146441 Cite \| Source
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients (journal article) Matsumoto, Morio \| Suzuki, Kenshi \| Kuroda, Junya \| Taniwaki, Masafumi \| Sunami, Kazutaka \| Kosugi, Hiroshi \| Ando, Kiyoshi \| Maruyama, Dai \| Tobinai, Kensei \| Kher, Uma \| ... \| Iida, Shinsuke International Journal of Hematology, volume 113, issue 6, pages 777-784 (2021). 10.1007/s12185-021-03139-1 Cited by (1) \| Cite \| Source
Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan (journal article) Yamasaki, Satoshi \| Iida, Hiroatsu \| Yoshida, Isao \| Komeno, Takuya \| Sawamura, Morio \| Matsumoto, Morio \| Sekiguchi, Naoshiro \| Hishita, Terutoshi \| Sunami, Kazutaka \| Shimomura, Takeshi \| ... \| Iwasaki, Hiromi Leukemia & Lymphoma (2021). 10.1080/10428194.2020.1845336 Cited by (3) \| Cite \| Source
Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma (journal article) Shibayama, Hirohiko \| Matsumoto, Morio \| Kosugi, Hiroshi \| Shibayama, Kazuhiro \| Yamazaki, Hiroshi \| Iida, Shinsuke International Journal of Hematology, volume 113, issue 1, pages 112-121 (2021). 10.1007/s12185-020-02985-9 Cited by (1) \| Cite \| Source
Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, phase 1/2, safety and efficacy study (journal article) Sunami, Kazutaka \| Suzuki, Kenshi \| Ri, Masaki \| Matsumoto, Morio \| Shimazaki, Chihiro \| Asaoku, Hideki \| Shibayama, Hirohiko \| Ishizawa, Kenichi \| Takamatsu, Hiroyuki \| Ikeda, Takashi \| ... \| Iida, Shinsuke Cancer Science, volume 111, issue 12, pages 4526-4539 (2020). 10.1111/cas.14657 Cited by (10) \| Cite \| Source
Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients (journal article) Takezako, Naoki \| Kosugi, Hiroshi \| Matsumoto, Morio \| Iida, Shinsuke \| Ishikawa, Takayuki \| Kondo, Yukio \| Ando, Kiyoshi \| Miki, Hirokazu \| Matsumura, Itaru \| Sunami, Kazutaka \| ... \| Suzuki, Kenshi International Journal of Hematology, volume 112, issue 5, pages 640-649 (2020). 10.1007/s12185-020-02953-3 Cited by (2) \| Cite \| Source
Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (journal article) Dimopoulos, Meletios A. \| Lonial, Sagar \| White, Darrell \| Moreau, Philippe \| Weisel, Katja \| San-Miguel, Jesus \| Shpilberg, Ofer \| Grosicki, Sebastian \| Špička, Ivan \| Walter-Croneck, Adam \| ... \| Richardson, Paul G. Blood Cancer Journal, volume 10, issue 9 (2020). 10.1038/s41408-020-00357-4 Cited by (98) \| Cite \| Source
PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma (journal article) Kasamatsu, Tetsuhiro \| Awata, Maaya \| Ishihara, Rei \| Murakami, Yuki \| Gotoh, Nanami \| Matsumoto, Morio \| Sawamura, Morio \| Yokohama, Akihiko \| Handa, Hiroshi \| Tsukamoto, Norifumi \| ... \| Murakami, Hirokazu Clinical and Experimental Medicine, volume 20, issue 1, pages 51-62 (2020). 10.1007/s10238-019-00585-4 Cited by (17) \| Cite \| Source
Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan (journal article) Kubo, Kohmei \| Hori, Mitsuo \| Ohta, Kensuke \| Handa, Hiroshi \| Hatake, Kiyohiko \| Matsumoto, Morio \| Hagiwara, Shotaro \| Ohashi, Kazuteru \| Nakaseko, Chiaki \| Suzuki, Kenshi \| ... \| Takezako, Naoki International Journal of Hematology, volume 111, issue 1, pages 65-74 (2020). 10.1007/s12185-019-02757-0 Cited by (11) \| Cite \| Source